Sectors
APLT
Applied Therapeutics, Inc.
0.10
2 x 0.09
11 x 0.11
bid
ask
+
0.00
0.00%
04:00 PM
timesize
| Ytd | 3.00% | |
| 1y | -81.62% |
0.10
day range
0.11
0.09
52 week range
1.50
| Open | 0.10 | Prev Close | 0.10 | Low | 0.10 | High | 0.11 | Mkt Cap | 14.86M |
| Vol | 0.00 | Avg Vol | 15.80M | EPS | -0.10 | P/E | -1.03 | Forward P/E | -1.85 |
| Beta | 2.08 | Short Ratio | 3.25 | Inst. Own | 103.35% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-13 | 50-d Avg | 0.15 | 200-d Avg | 0.46 | 1yr Est | 5.92 |
| Income Statement | |||
| Total Revenue | 1000.00K | ||
| Revenues (USD) | 1000.00K | ||
| Gross Profit | 1000.00K | ||
| Operating Expenses | 17.76M | ||
| Research and Development Expense | 9.60M | ||
| Selling, General and Administrative Expense | 8.16M | ||
| Operating Income | -16.76M | ||
| Net Income | -18.99M | ||
| Net Income Common Stock | -18.99M | ||
| Net Income Common Stock (USD) | -18.99M | ||
| Consolidated Income | -18.99M | ||
| Earnings per Basic Share | -0.13 | ||
| Earnings per Basic Share (USD) | -0.13 | ||
| Earnings per Diluted Share | -0.13 | ||
| Earning Before Interest & Taxes (EBIT) | -18.99M | ||
| Earning Before Interest & Taxes (USD) | -18.99M | ||
| Weighted Average Shares | 145.56M | ||
| Weighted Average Shares Diluted | 145.56M | ||
| Balance Sheet | |||
| Cash and Equivalents | 11.95M | ||
| Cash and Equivalents (USD) | 11.95M | ||
| Current Assets | 31.65M | ||
| Property, Plant & Equipment Net | 2.47M | ||
| Total Assets | 34.37M | ||
| Debt Current | 467.00K | ||
| Total Debt | 2.50M | ||
| Current Liabilities | 32.90M | ||
| Debt Non-Current | 2.03M | ||
| Total Liabilities | 34.94M | ||
| Accumulated Retained Earnings (Deficit) | -636.35M | ||
| Shareholders Equity | -561.00K | ||
| Shareholders Equity (USD) | -561.00K | ||
| Assets Non-Current | 2.72M | ||
| Total Debt (USD) | 2.50M | ||
| Liabilities Non-Current | 2.03M | ||
| Trade and Non-Trade Payables | 4.80M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 111.00K | ||
| Net Cash Flow from Financing | -75.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -18.48M | ||
| Issuance (Purchase) of Equity Shares | 19.00K | ||
| Net Cash Flow from Operations | -18.40M | ||
| Share Based Compensation | 1.14M | ||